Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study

Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis

(2015) Kentaro Ikeya et al.   DIGESTIVE AND LIVER DISEASE

Long-term Outcomes in Steroid-refractory Ulcerative Colitis Treated with Tacrolimus Alone or in Combination with Purine Analogues

(2015) K. J. Schmidt et al.   Journal of Crohns & Colitis

Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience

(2013) D. Laharie et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients

(2013) Jun Miyoshi et al.   Journal of Crohns & Colitis

PharmGKB summary

(2013) Julia M. Barbarino et al.   Pharmacogenetics and Genomics

Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis

(2012) Kah Hoong Chang et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: Early and long-term data from a retrospective observational study

(2012) Filippo Mocciaro et al.   Journal of Crohns & Colitis

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

(2012) David Laharie et al.   LANCET

Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

(2011) William J. Sandborn et al.   GASTROENTEROLOGY

Infliximab or Cyclosporine as Rescue Therapy in Hospitalized Patients with Steroid-Refractory Ulcerative Colitis: A Retrospective Observational Study

(2011) Mats Sjöberg et al.   INFLAMMATORY BOWEL DISEASES

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

(2011) Haruhiko Ogata et al.   INFLAMMATORY BOWEL DISEASES

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis

(2008) S. YAMAMOTO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

(2008) E.F. Stange et al.   Journal of Crohns & Colitis